NEWTOWN, Pa., April 20 /PRNewswire/ -- CONNEXION Healthcare (CXHC) announces the recent addition of Beth Joy-Dougherty as Director, New Business Development. In this role, Beth will be responsible for further development and growth of CXHC, including its Clinical CONNEXION and Publication CONNEXION business units.
Beth comes to CXHC with more than 16 years of pharmaceutical marketing and sales experience. Most recently, Beth served as Director of Key Account Development for Poretta & Orr, where she defined strategic platforms, focusing on business strategies and developing programs for specific target audiences. She cultivated successful long-range marketing programs, including product launch, direct-to-physician, direct-to-patient, and direct-to-consumer programs. Prior to her experience at Poretta & Orr, Beth served in Creative Services roles for Creative Marketing Alliance and Bristol Myers Squibb.
According to Michael Forte, Chief Operations Officer at CXHC, "With her unique blend of strategic marketing and sales expertise as well as knowledge and experience of diverse therapeutic areas, Beth will be a major contributor to the success and expansion of CXHC."
Grounded in science and inspired by passion, CXHC is a group of independent but complementary healthcare communications companies dedicated to developing high-quality scientific programs. Its mission is to educate, motivate, and inspire healthcare professionals across all therapeutic areas to help improve patient care. CXHC is committed to the knowledge that innovative solutions, quality execution, business integrity, and results are the keys to forging strong and enduring business relationships. This philosophy guides the company's 3 main operating units: Clinical CONNEXION (CCX), a full-service healthcare communications company; Publication CONNEXION (PCX), a strategic publications planning company; and Excellence in Medical Education (XME)
|SOURCE CONNEXION Healthcare|
Copyright©2009 PR Newswire.
All rights reserved